Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy Bellicum Pharmaceuticals (BLCM) stocks in Canada
Learn how to easily invest in Bellicum Pharmaceuticals stocks.
Bellicum Pharmaceuticals is a biotechnology business based in the US. Bellicum Pharmaceuticals stocks (BLCM.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $3.05 – a decrease of 0.68% over the previous week. Bellicum Pharmaceuticals employs 7 staff and has a trailing 12-month revenue of around $6.2 million.
How to buy shares in Bellicum Pharmaceuticals
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – BLCM – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
- Can I buy shares in Bellicum Pharmaceuticals?
- Has coronavirus impacted Bellicum Pharmaceuticals shares?
- Bellicum Pharmaceuticals shares summary
- Compare share dealing platforms
- Is Bellicum Pharmaceuticals stock a buy or sell?
- Bellicum Pharmaceuticals performance over time
- Are Bellicum Pharmaceuticals shares over-valued?
- Bellicum Pharmaceuticals's financials
- How volatile are Bellicum Pharmaceuticals shares?
- Does Bellicum Pharmaceuticals pay a dividend?
- Have Bellicum Pharmaceuticals shares ever split?
- Other common questions
Bellicum Pharmaceuticals stock price (NASDAQ:BLCM)Use our graph to track the performance of BLCM stocks over time.
Bellicum Pharmaceuticals shares at a glance
|Latest market close||$1.45|
|52-week range||$1.43 - $8.15|
|50-day moving average||$1.72|
|200-day moving average||$2.69|
|Wall St. target price||$4.50|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$0.69|
Compare online stock trading platforms
Note: The dollar amounts in the table below are in Canadian dollars.
Is it a good time to buy Bellicum Pharmaceuticals stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Bellicum Pharmaceuticals price performance over time
|1 week (2022-01-14)||-0.68%|
|1 month (2021-12-20)||-15.20%|
|3 months (2021-10-19)||-35.84%|
|6 months (2021-07-22)||-51.51%|
|1 year (2021-01-22)||-65.23%|
|2 years (2020-01-22)||-31.92%|
|3 years (2019-01-22)||3.23|
|5 years (2017-01-20)||12.55|
Is Bellicum Pharmaceuticals under- or over-valued?
Valuing Bellicum Pharmaceuticals stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Bellicum Pharmaceuticals's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Bellicum Pharmaceuticals's P/E ratio
Bellicum Pharmaceuticals's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 2x. In other words, Bellicum Pharmaceuticals shares trade at around 2x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Bellicum Pharmaceuticals financials
|Revenue TTM||$6.2 million|
|Gross profit TTM||$-38,552,000|
|Return on assets TTM||-46.66%|
|Return on equity TTM||-378.68%|
|Market capitalisation||$12.3 million|
TTM: trailing 12 months
Bellicum Pharmaceuticals share dividends
We're not expecting Bellicum Pharmaceuticals to pay a dividend over the next 12 months.
Have Bellicum Pharmaceuticals's shares ever split?
Bellicum Pharmaceuticals's shares were split on a 1:10 basis on 6 February 2020. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Bellicum Pharmaceuticals shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for Bellicum Pharmaceuticals shares which in turn could have impacted Bellicum Pharmaceuticals's share price.
Bellicum Pharmaceuticals share price volatility
Over the last 12 months, Bellicum Pharmaceuticals's shares have ranged in value from as little as $1.43 up to $8.15. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Bellicum Pharmaceuticals's is 1.4866. This would suggest that Bellicum Pharmaceuticals's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Bellicum Pharmaceuticals overview
Bellicum Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company, focuses on discovering and developing novel cellular immunotherapies for the treatment of hematological cancers and solid tumors in the United States and internationally. The company's clinical product candidates include BPX-601, an autologous GoCAR-T product candidate, which is in Phase 1/2 clinical trials for the treatment of solid tumors expressing the prostate stem cell antigen; and BPX-603, a dual-switch GoCAR-T product candidate that is in Phase 1/2 clinical trials to treat solid tumors that express the human epidermal growth factor receptor 2 antigens. Its clinical product candidates also include Rivo-cel, an allogeneic T cell product candidate intended to enhance outcomes when administered after hematopoietic stem cell transplantation in the treatment of hematologic malignancies and inherited blood disorders. It has collaboration and license agreements with Adaptimmune Therapeutics plc; Agensys, Inc. ; BioVec Pharma, Inc. ; ARIAD Pharmaceuticals, Inc.
Stocks similar to Bellicum Pharmaceuticals
Bellicum Pharmaceuticals in the news
Microsoft's $68.7 billion deal for Activision once again shows big tech's dominance over legacy media
Supreme Court vaccine mandate ruling won't bar companies from demanding Covid shots for workers — Biden vows to advocate for that
Two of Sen. Kyrsten Sinema's former aides have lobbied for corporate giants looking to influence Joe Biden's agenda
Frequently asked questions
More guides on Finder
How to buy Haemonetics Corporation stock in Canada
Steps to owning and managing HAE stock, with 24-hour and historical pricing before you buy.
How to buy Aritzia stock in Canada
Steps to owning and managing Aritzia (ATZ) stock, with 24-hour and historical pricing before you buy.
Hifi Finance (MFT) price prediction
Read our expert analysis on Hifi Finance and how the token will perform in the future.
Kusama (KSM) price prediction
Read our expert analysis on Kusama and how the token will perform in the future.
How to buy The Sandbox (SAND) in Canada
This guide provides step-by-step instructions on how to buy The Sandbox, lists some exchanges where you can get it and provides daily price data on SAND.
Shiba Inu (SHIB) price, history and performance
This guide explores the different ways of buying Shiba Inu on a cryptocurrency exchange as well as where you should store your cryptocurrency.
Baby Doge Coin (BABYDOGE) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Baby Doge Coin, lists some exchanges where you can get it and provides daily price data on BABYDOGE.
Pendle (PENDLE) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Pendle, lists some exchanges where you can get it and provides daily price data on PENDLE.
Hempcoin (THC) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Hempcoin, lists some exchanges where you can get it and provides daily price data on THC.
The ChampCoin (TCC) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy The ChampCoin, lists some exchanges where you can get it and provides daily price data on TCC.